Report Highlights
The major U.S. forensic products and services market reached $10.9 billion in 2012. This market is expected to grow to $11.2 billion in 2013 and nearly $16.3 billion in 2018, a compound annual growth CAGR of 7.8% for the period 2013 to 2018.
Report Includes
- An overall study of the U.S. forensic science market.
- Analyses of forensic technologies market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Information on all areas of the forensics market including: identification of current and future technologies, products, market segments/end markets, and government and regulatory agencies.
- Information on participating companies in light of technological strengths and weaknesses, relative market share, marketing strengths and innovative marketing practices.
- Information on major patents filed.
Report Scope
In preparing this report, an overall study of the crime laboratory segment of the U.S. forensic science market was undertaken. Related areas provided key information as well, as newer areas such as computer forensics make up a growing share of the total forensics business. All areas of the forensics market are addressed including: identification of current and future technologies, products, market segments/end markets, and government and regulatory agencies. Participating companies are discussed in light of technological strengths and weaknesses, relative market share, marketing strengths and innovative marketing practices.
Analyst Credentials
Kevin Gainer, research analyst, holds both B.A. and M.A. degrees in economic analysis and forecasting and has over 25 years of economic and market research experience. He is the author of six published books and dozens of technical papers, analyses and studies published in conference proceedings, including many unpublished proprietary analyses within corporations. He has worked as a Research Editor and Project Analyst at BCC Research since 1985, and has authored numerous BCC technology market research reports and periodicals.
Report Highlights
BCC estimates that total sales of forensic products and services were nearly $10.1 billion in 2010 and that sales will grow at a 9.4% compound annual growth rate (CAGR) through 2016 to more than $17 billion.
Report Highlights
- The U.S. market for forensic products and services increased from $9.5 billion in 2007 to an estimated $10.3 billion by the end of 2008. It should reach $17.5 billion by 2013, a com¬pound annual growth rate (CAGR) of 11%.
- DNA testing has become the definitive forensic technology. Other technologies such as blood group identification have become obsolete.
- Fingerprinting continues to move rapidly away from ink-based methods to biometric tech¬nologies such as electronic fingerprinting and electronic scanners.
Report Highlights
-
The overall U.S. value of forensic products reached nearly $1.48 billion in 2004 and is projected to rise at an AAGR (average annual growth rate) of 14.3% to more than $3.29 billion in 2010.
-
DNA testing is expected to grow at a 15.9% AAGR, rising from $745.2 million to more than $1.75 billion in the period.
-
Fingerprinting/biometrics are forecasted to grow at a 13.8% AAGR, rising to some $1.38 billion from $637.7 million in 2004.
-
The majority of forensic testing is done in publicly funded laboratories. Only a few private consultant laboratories offer services to analyze forensic evidence in the U.S.
Related Reports
Global Markets for Spectroscopy Equipment
The global spectrometry market increased from $7.8 billion in 2011 to $8.5 billion in 2012 and is expected to reach $14.8 billion in 2017, a compound annual growth rate (CAGR) of 11.7% for the forecast period of 2012 to 2017.
Surveillance and Security Equipment: Technologies and Global Markets
The total market demand for surveillance equipment reached nearly $80 billion in 2011 and $81.3 billion in 2012. It will further grow to $127.6 billion by 2017, a compound annual growth rate (CAGR) of 9.4% between 2012 and 2017.
Biologic Imaging Reagents: Technologies and Global Markets
The global market for biologic imaging reagents was valued at $9.4 billion in 2011 and is expected to reach $9.9 billion in 2012. Total market value is expected to reach nearly $14.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 7.8%.
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets
The global aptamer market was valued at $40 million in 2011 and should reach nearly $99 million in 2012. Total market value is expected to reach nearly $3.7 billion in 2017 with a five-year compound annual growth rate (CAGR) of 106.3%.
Recent Reports
Forensic Technologies: New and Growing Markets
The global market for forensics technology is estimated to increase from $20.9 billion in 2022 to reach $42.1 billion by 2027, at a compound annual growth rate (CAGR) of 15.0% from 2022 through 2027.
Surveillance and Monitoring of Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Hazards
The global chemical, biological, radiological, nuclear and explosive (CBRNE) equipment market should reach $25.4 billion by 2027 from $19.0 billion in 2022 at a compound annual growth rate (CAGR) of 5.9% for the forecast period of 2022 to 2027.
Identity Verification: Global Markets
The global identity verification market should reach $17.7 billion by 2026 from $8.0 billion in 2021 at a compound annual growth rate (CAGR) of 17.1% for the forecast period of 2021 to 2026.
Global Video Surveillance and VSaaS Market
The global market for video surveillance systems and VSaaS should grow from $40.0 billion in 2020 to $76.1 billion by 2025, at compound annual growth rate (CAGR) of 13.8% for the period of 2020-2025.
Anti-counterfeiting, Authentication and Verification Technologies
The global anti-counterfeiting, authentication and verification technologies market should grow from $105.9 billion in 2018 to $184.6 billion by 2023 at a compound annual growth rate (CAGR) of 11.8% for the period of 2018-2023.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More